Daxdilimab
Daxdilimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Daxdilimab is under investigation in clinical trial NCT04526912 (Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection).
| Trade Name | Daxdilimab |
| Generic | Daxdilimab |
| Daxdilimab Other Names | Daxdilimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
How Daxdilimab works
Daxdilimab is a novel drug designed to target and bind to ILT7, which is a cell surface molecule specific to the pDC type of dendritic cells. It is currently being investigated against autoimmune diseases and COVID-19.
Innovators Monograph
You find simplified version here Daxdilimab
